Cargando…

Lung microbiome in children with hematological malignancies and lower respiratory tract infections

BACKGROUND: Respiratory infectious complications remain a major cause of morbidity and mortality in children with hematological malignancies. Knowledge regarding the lung microbiome in aforementioned children is limited. METHODS: A prospective cohort was conducted, enrolling 16 children with hematol...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Yun, Ning, Haonan, Zheng, Wenyu, Liu, Jing, Li, Fuhai, Chen, Junfei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9533145/
https://www.ncbi.nlm.nih.gov/pubmed/36212487
http://dx.doi.org/10.3389/fonc.2022.932709
_version_ 1784802281266348032
author Zhang, Yun
Ning, Haonan
Zheng, Wenyu
Liu, Jing
Li, Fuhai
Chen, Junfei
author_facet Zhang, Yun
Ning, Haonan
Zheng, Wenyu
Liu, Jing
Li, Fuhai
Chen, Junfei
author_sort Zhang, Yun
collection PubMed
description BACKGROUND: Respiratory infectious complications remain a major cause of morbidity and mortality in children with hematological malignancies. Knowledge regarding the lung microbiome in aforementioned children is limited. METHODS: A prospective cohort was conducted, enrolling 16 children with hematological malignancies complicated with moderate-to-severe lower respiratory tract infections (LRTIs) versus 21 LRTI children with age, gender, weight, and infection severity matched, with no underlying malignancies, to evaluate the lung microbiome from bronchoalveolar lavage fluid samples in different groups. RESULTS: The lung microbiome from children with hematological malignancies and LRTIs showed obviously decreased α and β diversity; increased microbial function in infectious disease:bacteria/parasite; drug resistance:antimicrobial and human pathogenesis than the control group; a significantly reduced proportion of Firmicutes, Bacteroidota, Actinobacteriota; increased Proteobacteria at the phylum level; and distinctly elevated Parabacteroides, Klebsiella, Grimontia, Escherichia_Shigella, unclassified_Enterobacteriaceae at the genus level than the control group. Furthermore, it was revealed that α diversity (Shannon), β diversity (Bray–Curtis dissimilarity), Proteobacteria at the phylum level, and unclassified_Enterobacteriaceae and Escherichia_Shigella at the genus level were significantly negatively associated with hospitalization course whereas Firmicutes at the phylum level was established positively correlated with the hospitalization course. CONCLUSIONS: Children with hematological malignancies and LRTIs showed obviously decreased α and β diversity, significantly increased function in infectious disease pathogenesis, antimicrobial drug resistance, and unfavorable environment tolerance. Moreover, α diversity (Shannon), β diversity (Bray–Curtis dissimilarity), and Proteobacteria may be used as negative correlated predictors for hospitalization course in these children whereas Firmicutes may be utilized as a positive correlated predictor.
format Online
Article
Text
id pubmed-9533145
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-95331452022-10-06 Lung microbiome in children with hematological malignancies and lower respiratory tract infections Zhang, Yun Ning, Haonan Zheng, Wenyu Liu, Jing Li, Fuhai Chen, Junfei Front Oncol Oncology BACKGROUND: Respiratory infectious complications remain a major cause of morbidity and mortality in children with hematological malignancies. Knowledge regarding the lung microbiome in aforementioned children is limited. METHODS: A prospective cohort was conducted, enrolling 16 children with hematological malignancies complicated with moderate-to-severe lower respiratory tract infections (LRTIs) versus 21 LRTI children with age, gender, weight, and infection severity matched, with no underlying malignancies, to evaluate the lung microbiome from bronchoalveolar lavage fluid samples in different groups. RESULTS: The lung microbiome from children with hematological malignancies and LRTIs showed obviously decreased α and β diversity; increased microbial function in infectious disease:bacteria/parasite; drug resistance:antimicrobial and human pathogenesis than the control group; a significantly reduced proportion of Firmicutes, Bacteroidota, Actinobacteriota; increased Proteobacteria at the phylum level; and distinctly elevated Parabacteroides, Klebsiella, Grimontia, Escherichia_Shigella, unclassified_Enterobacteriaceae at the genus level than the control group. Furthermore, it was revealed that α diversity (Shannon), β diversity (Bray–Curtis dissimilarity), Proteobacteria at the phylum level, and unclassified_Enterobacteriaceae and Escherichia_Shigella at the genus level were significantly negatively associated with hospitalization course whereas Firmicutes at the phylum level was established positively correlated with the hospitalization course. CONCLUSIONS: Children with hematological malignancies and LRTIs showed obviously decreased α and β diversity, significantly increased function in infectious disease pathogenesis, antimicrobial drug resistance, and unfavorable environment tolerance. Moreover, α diversity (Shannon), β diversity (Bray–Curtis dissimilarity), and Proteobacteria may be used as negative correlated predictors for hospitalization course in these children whereas Firmicutes may be utilized as a positive correlated predictor. Frontiers Media S.A. 2022-09-21 /pmc/articles/PMC9533145/ /pubmed/36212487 http://dx.doi.org/10.3389/fonc.2022.932709 Text en Copyright © 2022 Zhang, Ning, Zheng, Liu, Li and Chen https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Zhang, Yun
Ning, Haonan
Zheng, Wenyu
Liu, Jing
Li, Fuhai
Chen, Junfei
Lung microbiome in children with hematological malignancies and lower respiratory tract infections
title Lung microbiome in children with hematological malignancies and lower respiratory tract infections
title_full Lung microbiome in children with hematological malignancies and lower respiratory tract infections
title_fullStr Lung microbiome in children with hematological malignancies and lower respiratory tract infections
title_full_unstemmed Lung microbiome in children with hematological malignancies and lower respiratory tract infections
title_short Lung microbiome in children with hematological malignancies and lower respiratory tract infections
title_sort lung microbiome in children with hematological malignancies and lower respiratory tract infections
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9533145/
https://www.ncbi.nlm.nih.gov/pubmed/36212487
http://dx.doi.org/10.3389/fonc.2022.932709
work_keys_str_mv AT zhangyun lungmicrobiomeinchildrenwithhematologicalmalignanciesandlowerrespiratorytractinfections
AT ninghaonan lungmicrobiomeinchildrenwithhematologicalmalignanciesandlowerrespiratorytractinfections
AT zhengwenyu lungmicrobiomeinchildrenwithhematologicalmalignanciesandlowerrespiratorytractinfections
AT liujing lungmicrobiomeinchildrenwithhematologicalmalignanciesandlowerrespiratorytractinfections
AT lifuhai lungmicrobiomeinchildrenwithhematologicalmalignanciesandlowerrespiratorytractinfections
AT chenjunfei lungmicrobiomeinchildrenwithhematologicalmalignanciesandlowerrespiratorytractinfections